EFFICACY AND SAFETY OF MAINTENANCE PEMETREXED IN PATIENTS WITH ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC) AFTER COMPLETING AT LEAST 4 CYCLES OF PEMETREXED PLUS CISPLATIN INDUCTION TREATMENT: A CROSS-TRIAL ANALYSIS OF TWO PHASE III TRIALS

被引：0

作者：

Scagliotti, Giorgio V. ^{[1
]}

Gridelli, Cesare ^{[2
]}

De Marinis, Filippo ^{[3
]}

Thomas, Michael ^{[4
]}

Dediu, Mircea

Pujol, Jean-Lois ^{[5
]}

Manegold, Christian ^{[6
]}

San Antonio, Belen

Peterson, Patrick M. ^{[7
]}

John, William J. ^{[7
]}

Chouaki, Nadia

Visseren-Grul, Carla ^{[8
]}

Paz-Ares, Luis G. ^{[9
]}

机构：

[1] Univ Turin, San Luigi Hosp, I-10124 Turin, Italy

[2] SG Moscati Hosp, Avellino, Italy

[3] High Specializat Hosp, Oncol Pulm Unit 1, San Camillo Forlanini, Italy

[4] Univ Klinikum Heidelberg, Thoraxklin, Heidelberg, Germany

[5] Montpellier Acad Hosp, Montpellier, France

[6] Heidelberg Univ, Med Ctr, D-69115 Heidelberg, Germany

[7] Eli Lilly & Co, Indianapolis, IN USA

[8] Eli Lilly & Co, Med Oncol, Houten, Netherlands

[9] Univ Hosp, Barcelona, Spain

来源：

关键词：

efficacy; safety; pemetrexed maintenance; nonsqamous NSCLC;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P2.10-037

引用

页码：S877 / S878

页数：2